These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12806375)

  • 1. PSA testing in general practice.
    Little B; Ho KJ; Gormley G; Young M
    Prostate Cancer Prostatic Dis; 2003; 6(2):154-8. PubMed ID: 12806375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
    Bunting PS; Goel V; Williams JI; Iscoe NA
    CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
    Jønler M; Eddy B; Poulsen J
    Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunistic prostate-specific antigen screening in Italy: 6 years of monitoring from the Italian general practice database.
    D'Ambrosio GG; Campo S; Cancian M; Pecchioli S; Mazzaglia G
    Eur J Cancer Prev; 2010 Nov; 19(6):413-6. PubMed ID: 20679895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSA testing in general practice.
    Hodgson F; Obertová Z; Brown C; Lawrenson R
    J Prim Health Care; 2012 Sep; 4(3):199-204. PubMed ID: 22946067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Has there been a change in practice of screening for prostate cancer with prostate-specific antigen in Ontario?
    Bunting PS
    Clin Biochem; 2004 Oct; 37(10):898-903. PubMed ID: 15369721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of PSA requests from general practitioners received by one Dublin hospital.
    McGing PG
    Ir Med J; 1998; 91(2):61-2. PubMed ID: 9617033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening of the prostate cancer. "lnstantaneous" of a daily practice among 300 general practitioners of the canton of Vaud].
    Praz V; Jichlinski P; Aymon D; Leisinger HJ
    Rev Med Suisse; 2005 Dec; 1(44):2840-2. PubMed ID: 16382715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for prostate cancer: a survey of New Zealand general practitioners.
    Durham J; Low M; McLeod D
    N Z Med J; 2003 Jun; 116(1176):U476. PubMed ID: 12835804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-specific patterns of prostate-specific antigen testing among primary care physician visits.
    McNaughton Collins M; Stafford RS; Barry MJ
    J Fam Pract; 2000 Feb; 49(2):169-72. PubMed ID: 10718695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early detection of prostate cancer by PSA testing: the results of a qualitative study on barriers caused by physicians in Austria implementing informed decision making].
    Malli G
    Gesundheitswesen; 2013 Jan; 75(1):22-8. PubMed ID: 22836936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen testing: uncovering primary care influences.
    Gormley GJ; Catney D; McCall JR; Reilly PM; Gavin AT
    BJU Int; 2006 Nov; 98(5):996-1000. PubMed ID: 17034601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PSA: the difficult position of general practitioners between patients and urologists].
    Vincendeau S; Abi Moussa M; Manunta A; Patard JJ; Guillé F; Lobel B
    Prog Urol; 2003 Apr; 13(2):252-5. PubMed ID: 12765060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSA testing in office-based clinics: are we testing as much as we think?
    González HM; West B; Underwood W
    J Am Coll Surg; 2005 Dec; 201(6):906-12. PubMed ID: 16310694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician clinical experience and inappropriate prostate specific antigen screening: evidence from an Asian country.
    Kuo NW; Lin HC; Lee HC
    J Urol; 2008 Nov; 180(5):1954-8; discussion 1958. PubMed ID: 18801533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does 'peer coaching' increase GP capacity to promote informed decision making about PSA screening? A cluster randomised trial.
    Gattellari M; Donnelly N; Taylor N; Meerkin M; Hirst G; Ward JE
    Fam Pract; 2005 Jun; 22(3):253-65. PubMed ID: 15824055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepancies between guidelines and clinical practice regarding prostate-specific antigen testing.
    Hamoen EH; Reukers DF; Numans ME; Barentsz JO; Witjes JA; Rovers MM
    Fam Pract; 2013 Dec; 30(6):648-54. PubMed ID: 24107269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Timely screening routines for prostatic cancer by Norwegian physicians].
    Fosså SD; Eri LM
    Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3572-6. PubMed ID: 10563174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PSA screening in New Zealand: total population results and general practitioners' current attitudes and practices.
    van Rij S; Dowell T; Nacey J
    N Z Med J; 2013 Aug; 126(1381):27-36. PubMed ID: 24150262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.
    Welch HG; Schwartz LM; Woloshin S
    J Natl Cancer Inst; 2005 Aug; 97(15):1132-7. PubMed ID: 16077071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.